SARCOMATOID RENAL CELL CARCINOMA
Clinical trials for SARCOMATOID RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SARCOMATOID RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SARCOMATOID RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Triple-Threat drug combo against Tough-to-Treat cancers
Disease control OngoingThis early-stage study is testing the safety and best doses of a combination of cancer drugs for people with advanced cancers of the urinary system (like bladder and kidney cancer) that have spread. The trial combines a pill (cabozantinib) that aims to block tumor growth with one…
Matched conditions: SARCOMATOID RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Head-to-Head kidney cancer drug trial seeks better control
Disease control OngoingThis study compares two existing drugs, cabozantinib and sunitinib, to see which is safer and more effective at controlling advanced kidney cancer that has spread. It is for patients with specific, less common types of kidney cancer. Participants are randomly assigned to take one…
Matched conditions: SARCOMATOID RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Berry boost for cancer fight? trial tests natural Add-On to immunotherapy
Disease control TerminatedThis early-stage study is testing if adding a natural berry supplement called camu camu makes standard immunotherapy drugs work better for people with advanced kidney cancer that has spread. The main goal is to check if the combination is safe and to find the right dose of camu c…
Matched conditions: SARCOMATOID RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Major trial aims to boost immune system to fight kidney cancer after surgery
Disease control OngoingThis large study is testing if adding an immunotherapy drug called nivolumab to standard kidney cancer surgery helps prevent the cancer from coming back. About 819 patients with kidney cancer that hasn't spread far will have surgery, with half also receiving the drug before and a…
Matched conditions: SARCOMATOID RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Major trial aims to boost survival for advanced kidney cancer
Disease control OngoingThis large, late-stage trial is testing if adding a drug called cabozantinib to a standard immunotherapy regimen helps patients with advanced kidney cancer that has spread. The study will compare how long patients live and how long their cancer is controlled on the new combinatio…
Matched conditions: SARCOMATOID RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC